Anzeige
Mehr »
Login
Donnerstag, 30.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Die neuen Aktien-Stars der nächsten Rallye-Stufe im Uransektor
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Übersicht Suchergebnisse zum Thema NOVABAY PHARMACEUTICALS

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
MiNovaBay Pharmaceuticals, Inc. - 8-K, Current Report7
MiNovaBay Pharmaceuticals Announces Approval of All Proposals at its 2024 Annual Meeting of Stockholders and Provides Other Corporate Updates29EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. the "Company") (NYSE American: NBY) announces that a quorum was reached and that all proposals in the Company's Definitive Proxy...
► Artikel lesen
20.05.NovaBay Pharmaceuticals Stock Is Up 50%: What's Going On?5
09.05.NovaBay Pharmaceuticals Reports First Quarter 2024 Financial Results67EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) reports financial results for the three months ended March 31, 2024 and provides a business update. "Net...
► Artikel lesen
22.04.NovaBay Pharmaceuticals receives NYSE notice for compliance8
19.04.NovaBay Pharmaceuticals, Inc. - 8-K, Current Report2
17.04.NovaBay Pharmaceuticals show 13% rise in eyecare and wound care segment - prelim report5
29.03.NovaBay Pharmaceuticals, Inc. - 10-K/A, Annual Report4
26.03.NovaBay Pharmaceuticals: Q4 Earnings Insights3
26.03.NovaBay Pharmaceuticals, Inc. - 10-K, Annual Report1
26.03.NovaBay Pharmaceuticals Reports 2023 Fourth Quarter and Full Year Financial Results51EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) reports financial results for the three and 12 months ended December 31, 2023 and provides a business update. "Quarterly...
► Artikel lesen
25.03.NovaBay Pharmaceuticals, Inc. - 8-K, Current Report2
14.03.NovaBay Pharmaceuticals, Inc. - 8-K, Current Report-
14.03.NovaBay Pharmaceuticals To Sell DERMAdoctor Skincare Business2
14.03.NovaBay Pharmaceuticals Announces Agreement to Sell its DERMAdoctor Skincare Business Segment; Announces Preliminary Financial Results for Fourth Quarter and Year Ended December 31, 2023135EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a company developing and commercializing high-quality eyecare and wound care products, announces that the...
► Artikel lesen
13.03.Eyenovia, Inc.: NovaBay Pharmaceuticals and Eyenovia to Co-Promote Prescription Ophthalmic Products to U.S. Eyecare Professionals1
30.01.NovaBay Pharmaceuticals posts 64% rise in 2023 Avenova unit subscription-based sales8
10.01.NovaBay Pharmaceuticals, Inc. - 8-K, Current Report5
09.01.Sonoma Pharmaceuticals, Inc.: NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonoma's Extensive Distributor Network593EMERYVILLE, CA and BOULDER, CO / ACCESSWIRE / January 9, 2024 / NovaBay Pharmaceuticals, Inc. (NYSE American:NBY) and Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) today announced an agreement for the...
► Artikel lesen
21.12.23NovaBay Pharmaceuticals, Inc. - 8-K, Current Report4
Seite:  Weiter >>